Zhonghua Wang

2.1k citations
57 papers · 1.3k indexed · h-index 20
Topics
Cancer Treatment and Pharmacology (20 papers)HER2/EGFR in Cancer Research (16 papers)Breast Cancer Treatment Studies (12 papers)
Partner nations
ChinaCanadaUnited States

In The Last Decade

Zhonghua Wang

53 papers receiving 1.3k citations

Peers

Zhonghua Wang
Comparison fields: 5 of 101
  • Oncology 683
  • Molecular Biology 415
  • Pulmonary and Respiratory Medicine 409
  • Cancer Research 265
  • Pathology and Forensic Medicine 114
Replace Ala Abudayyeh with:
Ala Abudayyeh United States
A. Lipton United States
Francesca Battaglin United States
Chellappagounder Thangavel United States
Jieqiong Liu China
Jun Cao China
Shingo Arakawa Japan
Anja J. Stauber United States
Ana L. Gomes United Kingdom
Shingo Sakashita Japan
Zhonghua Wang relative to Ala Abudayyeh United States Ala Abudayyeh's profile →
Citations per field
00.5×1.5×
Ala Abudayyeh · 1×
Citations per year

Countries citing papers authored by Zhonghua Wang

Since Specialization
Citations

This map shows the geographic impact of Zhonghua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghua Wang more than expected).

Fields of papers citing papers by Zhonghua Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghua Wang. The network helps show where Zhonghua Wang may publish in the future.

Co-authorship network of co-authors of Zhonghua Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghua Wang. A scholar is included among the top collaborators of Zhonghua Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghua Wang. Zhonghua Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 3
4 3
5 39
6 1
7 6
8 26
9 5
10 61
11 67
12 49
13 6
14 21
15 19
16 176
17 37
18 16
19 16
20 85

About Zhonghua Wang

Zhonghua Wang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), HER2/EGFR in Cancer Research (16 papers) and Breast Cancer Treatment Studies (12 papers). The work is most often cited by research in Oncology (683 citations), Cancer Research (265 citations) and Aging (24 citations). Zhonghua Wang has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Biyun Wang, Xichun Hu, Jian Zhang, Jun Cao, Michał M. Masternak, Zhongsheng Tong, Leiping Wang, Khalid Al-Regaiey, A. Bartke and Si Sun. Their work appears in journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026